INTRODUCTION
In recent years, periodontal disease has been implicated in the onset and development of cardiovascular diseases, including atherosclerosis, cerebrovascular and coronary artery diseases, rheumatoid arthritis, diabetes mellitus, occlusive respiratory diseases and preterm low birth weight.
Chronic low-grade inflammation is emerging as a conceivable etiologic mechanism linking periodontal disease and the conditions cited above, as well as other systemic diseases. IL-6 is the main procoagulant cytokine 2004) . It can increase plasma concentrations of fibrinogen and plasminogen activator inhibitor type-1, as well as induce the expression of CRP, which amplifies inflammatory and pro-coagulant 1 responses.
CRP is associated with endothelial cell damage and it has been viewed as a m a r k e r o f l o w -g r a d e v a s c u l a r inflammation. CRP has received a great deal of attention because it is now considered a risk factor for cardiovascular events when its levels are > 0.21 mg/dl and Serum CRP level closely reflects the extent and activity of diseases.
Recent investigations suggested that even a moderate increase in Creactive protein (CRP) levels (Range of 0.1-0.3 mg/dl), such as those found in periodontitis patients, may predict a risk for atherosclerosis and coronary vascular diseases.
Although many studies have compared circulating IL-6 and CRP concentrations in periodontal patients and The CRP was discovered in 1930 by Tillet and Francis. They were investigating serological reactions in pneumonia with various extracts of pneumococci and observed that a non-specific somatic polysaccharide fraction, which they designated fraction C, was precipitated by the sera of acutely ill patients. After the crisis was over, the capacity of the patients sera to precipitate C polysaccharide (CPS) rapidly disappeared, and the C-reactive material was not found in sera from normal healthy individuals. Avery (1941) and his collaborators characterized the C-reactive material as a protein which required calcium ions for its reaction with CPS (C-polysaccharide) and introduced the term "acute phase" to refer to serum from patients acutely ill with infectious disease and containing the C-reactive protein.
CRP was the first protein to be discovered which behaves as an acute phase reactant, and was named for its calcium dependent interaction with the somatic C-polysaccharide of pneumococci, in which CRP recognizes phosphocholine residues. CRP also binds to other substances which contain phosphocholine, including phospholipids, some plasma lipoproteins and the plasma membranes of damaged or apoptotic but not intact cells. In addition, CRP binds specifically to small nuclear ribonucleoprotein particles when these are exposed in dead or damaged cells.
C-reactive protein is normally present in minute quantities but may increase dramatically within 72 hours following tissue injury. CRP is a trace protein in overtly normal, healthy individuals. A written informed willingness to participate was taken in the consent form duly signed by the patient. The study was carried out as per the Declaration of Helsinki (1964) and was also approved by the Institutional Ethical board.
Patients of either sex, aged between 30 to 70 years, with a minimum of 20 teeth were selected randomly and each subject had probing pocket depth equal to or more than 5 mm accompanied with loss of attachment and/or radiographic evidence of alveolar bone loss.
Patients were not included in the study if they were pregnant or lactating women; if they had undergone any periodontal treatment or tooth extraction in the last 6 months or taken any anti inflammatory drug therapy, antibiotics, steroids in the last 6 months. Patients with adverse habits such as tobacco and alcohol abuse were also excluded from the study.
All the selected subjects were evaluated clinically to assess the following periodontal measurements: number of teeth, probing pocket depth, clinical attachment levels, plaque index (PI) by Silness & Loe, and gingival index (GI) by Loe & Silness. Four sites were examined on each tooth: facial or buccal, mesial, distal and lingual/palatal. One trained examiner took all measurements and recorded the results. All the patients were evaluated clinically after two months of non-surgical periodontal therapy to reassess the periodontal measurements described previously.
The serum C reactive protein level assessment was carried out by drawing 5ml of fasting venous blood sample from selected patients pre-operatively and postoperatively. The collected blood sample was allowed to coagulate for 30 minutes at 37°C to get the serum sample by centrifugation using a tabletop centrifuge (REMY Laboratories) at 2000 rpm for 15 minutes. The serum C reactive protein level of each patient was quantified using Turbidimetric Immunoassay for Ultrasensitive Determination (By Quantia-US).
Scoring criteria:
Non-surgical periodontal therapy: StatisticalAnalysis :
The selected patients were treated with nonsurgical periodontal therapy which included scaling, root planing and subgingival irrigation with normal saline. Coronoplasty was done in patients where indicated. Oral hygiene measures included the demonstration of manual tooth brushing techniques and patients were instructed and motivated to brush their teeth twice daily and rinse their mouth after every meal. Also, dental floss and interdental brush were advised where indicated. Patients were then periodically monitored after the periodontal therapy at one month for reinforcement of the oral hygiene instructions and then at two months for assessment of clinical parameters and laboratory investigations.
The pre-operative and post-operative values of all the clinical parameters and serum C reactive protein levels, so obtained, were subjected to the statistical analysis. The descriptive statistical analysis was carried out in the study. Results on continuous measurements are presented on Mean SD (Min-Max). Student's paired 't Test was used to find the significance of study parameters on continuous scale pre-operatively and post-operatively after two months.
Thirty patients with generalized chronic periodontitis were enrolled in the study with the age range between 32 to 67 years of which 16 were males and 14 were females. All the patients were inhabitants of Haryana state in India and the socio-economic status ranged from fair to poor.
The mean pre-operative serum C-reactive protein level was 0.65 ± 0.379 and the mean postoperative level after two months of non-surgical therapy was 0.40 ± 0.341 which was highly significant (P value < 0.001) . Table 1 shows the mean pre-operative and post-operative values for plaque index, gingival index, probing pocket depth, clinical attachment level and serum C-reactive protein level along with standard deviation and standard error. Table 2 shows the mean reduction and the percentage reduction in the plaque index, gingival index, probing pocket depth, clinical attachment level and serum C reactive protein level after two months of non-surgical periodontal therapy.
The t value and p value are shown in table 2. P value is significant for all the above mentioned clinical parameters and serum C-reactive protein level which shows that non-surgical periodontal therapy has a positive effect on lowering the levels of serum Creactive protein. 
'

RESULTS
Study Population characteristics
DISCUSSION
The results of this study shows that nonsurgical periodontal therapy significantly lowers the serum levels of C-reactive protein along with other clinical parameters like plaque index, gingival index, probing pocket depth and causes gain in clinical attachment level in patients with generalized chronic periodontitis.
The results of the present study shows a reduction in C reactive protein level which is in line with other studies.
Conversely In the present study, the blood samples were collected two months after the periodontal therapy because this is considered as an ideal time period to evaluate periodontal healing after non-surgical periodontal treatment.
The baseline values of inflammatory marker, susceptibility of the patients, selection criteria of the studied population, and differences in the severity of periodontal disease may explain some of the discrepancies in the results compared to previous studies. All clinical parameters improved after nonsurgical periodontal therapy probably because oral hygiene instructions were given to the patients which were reinforced at one month interval. Oral hygiene measures included the demonstration of manual tooth 13 brushing techniques and patients were instructed and motivated to brush their teeth twice daily and rinse their mouth after every meal. Also, dental floss and interdental brush were advised where indicated.
Limitations of this study includes a relatively small sample size, which may affect the reproducibility of the results, and the short observation period (2 months). Prospective studies with a larger sample size and longer observation periods are required to evaluate the benefits of reducing serum C reactive protein levels which can be further used as a way of decreasing the global cardiovascular risk for patients.
The observations made by the serum C-reactive protein levels and various other clinical parameters suggest that non-surgical periodontal therapy can be effectively used in significantly lowering the serum levels of C-reactive protein in all the patients with generalized chronic periodontitis. Hence, serum Creactive protein assessment may be used as a diagnostic and prognostic marker of inflammation and tissue injury which may benefit the medically compromised patients in reducing the risk of various cardiovascular events like -coronary artery diseases, chronic heart diseases, myocardial infarction etc.
